SEC Form 4 · accession 0001144204-16-104222
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gang Cbpo Yang
Officer — Corporate Vice President
Period of report
May 16, 2016
Accepted (ET)
May 23, 2016 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2016 | M | 40,000 | $12.26 | A | 62,205 | D | |
| Common StockF1,F2 | May 19, 2016 | S | 14,858 | $113.83 | D | 47,347 | D | |
| Common StockF1,F3 | May 20, 2016 | S | 11,705 | $113.40 | D | 35,642 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $12.26 | May 16, 2016 | M | 40,000 | D | Oct 11, 2010 | Jul 11, 2020 | Common Stock | 40,000 | 15,000 | D |
| Stock Option (right to buy)F5 | $9.85 | May 16, 2016 | M | 11,250 | D | Sep 1, 2013 | Aug 31, 2022 | Common Stock | 11,250 | 3,750 | D |
Explanation of responses
- F1Represents 14,858 shares of common stock (the "May 19 Sold Common Stock") sold on the open market at a weighted average price of $113.83 per share on May 19, 2016, and 11,705 shares of common stock (the "May 20 Sold Common Stock," and together with the May 19 Sold Common Stock, the "Sold Stock") sold on the open market at a weighted average price of $113.40 per share on May 20, 2016. The Sold Stock was acquired by the Reporting Person through the exercise of stock options to purchase 40,000 shares of the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options. The Reporting Person intends to use the proceeds from the sales of the Sold Stock to pay income tax due in connection with the Reporting Person's exercise of the stock options disclosed in Footnotes 4 and 5 to this Form 4.
- F2The price reported in Column 4 is a weighted average price. The May 19 Sold Common Stock was sold in multiple transactions in the open market at prices ranging from $113.50 to $115.35, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3 to this Form 4.
- F3The price reported in Column 4 is a weighted average price. The May 20 Sold Common Stock was sold in multiple transactions in the open market at prices ranging from $113.00 to $114.00, inclusive.
- F4Represents previously reported stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated July 11, 2010. The options were scheduled to vest in 12 equal portions on a quarterly basis over a three-year period, with the initial vesting date being October 11, 2010, provided that the Reporting Person is employed by the Issuer on each vesting date.
- F5Represents previously reported stock options to purchase 11,250 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.